#ICYMI : The results of the SHASTA-2 trial were presented at American College of Cardiology's Annual Scientific Session.
Dr. Robert S Rosenson of Mount Sinai Fuster Heart Hospital shares key highlights of the trial.

The trial found that the investigational drug, plozasiran, reduced #triglyceride levels by an average of

We are thrilled to announce that Dr. Gilbert Tang
and Joshua Lampert, MD of Mount Sinai Fuster Heart Hospital has been honored with the prestigious 2023 Simon Dack Award for Outstanding Scholarship, recognizing their contributions to the mission of JACC Journals to publish new and important clinical

Mount Sinai researchers, in collaboration with scientists at Rockefeller University, have uncovered a mechanism in the brain that allows addictive drugs to take over natural reward processing systems: mshs.co/4di5xfk

Eric J. Nestler, MD, PhD Vaziri Lab Caleb Browne Bowen Tan Friedman Brain Institute

New findings in mice from the #FriedmanLab , the #VaziriLab , and colleagues at Icahn School of Medicine at Mount Sinai may explain how addictive drugs hiijack natural reward processing systems, creating the urge to use while throwing natural urges to eat and drink off-kilter. rockefeller.edu/news/35742-new…

Congratulations, Dr. Miriam Merad, MD, PhD on this well-deserved achievement!

Fondation ARC The Tisch Cancer Institute Lipschultz Precision Immunology Institute

#Cancer #Research

.Shahram Majidi, MD, MD, Assistant Professor of Mount Sinai Neurosurgery, Neurology, and Radiology, and Director of Cerebrovascular Services at Mount Sinai Brooklyn, working with engineers from Synchron.

Video Credit: Synchron

#BrainComputerInterface #Neurosurgery

Celebrating Dr. Valentin Fuster's Contributions to Cardiovascular Medicine and Science.

View this special tribute video by American College of Cardiology, honoring the impact of Valentin Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, on American College of Cardiology, JACC Journals, and the cardiovascular

.SBDRC at Mount Sinai w-Dr. Elena Ezhkova hosted a Joint Retreat today. Our Dr. Andrew Ji moderated w-discussion panelists: Dr. Patrick Brunner & Dr. Benjamin Ungar “Uniting Basic Science & Clinical Practice”. Keynote Address: Ting Chen, PhD, from Beijing, China. Emma Guttman-Yassky

Congratulations, Bravo-Cordero Lab, on this well-deserved achievement!

Register today for The New Wave of AI in Healthcare 2024 to hear from keynote speaker Dr. Melanie Mitchell (Melanie Mitchell) on 'The Past, Present, and Uncertain Futures of AI.' mshs.co/4cYlgjy

#NewWaveAIHealth #ArtificialIntelligence AI and Human Health at Mount Sinai NYAS

At #ExploreIcahn , accepted applicants participated in advanced scientific lectures, clinical skills sessions, and workshops that foster thoughtful discussions on issues that intersect equity, justice, and health care. #MedEd

During our #ExploreIcahn weekend, we offered panel discussions with Icahn School of Medicine at Mount Sinai faculty, students, and recent alumni.

We invited all accepted applicants back this weekend to the Icahn School of Medicine at Mount Sinai for #ExploreIcahn weekend. #MedEd

We are excited to announce that one of our students, Sai Kaushik Yeturu, has been selected for the 2024 Medical Program of the Fellowships at Auschwitz for the Study of Professional Ethics (FASPE). Yeturu is among 14 medical students chosen for this prestigious program.

Check out highlights from Anu Lala-Trindade's discussions on the latest research from #ACC24 ! Dr. Lala shares key takeaways from the DanGer Shock trial, REDUCE-AMI study, ARISE-HF study, and the EMPACT-MI trial. Don't miss out on these important insights!

Mount Sinai Fuster Heart Hospital American College of Cardiology

Withdrawing aspirin one month after percutaneous coronary intervention (PCI) in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared to patients taking aspirin and ticagrelor combined

Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be beneficial to heart failure patients with reduced left ventricular ejection